Proteomic analysis identifies GSN as a non-invasive circulating serum biomarker for predicting early recurrence of hepatocellular carcinoma
Published: 22 December 2023| Version 1 | DOI: 10.17632/kc6mnp6jrw.1
Contributor:
En HuDescription
The Data for each figure.
Files
Categories
Proteomics, Expression Proteomics